A case of psoriasis complicated by breast cancer after systemic treatments including biologics

Shin Morizane, Saeko Sugimoto, Takayuki Motoki, Norihisa Katayama, Masako Omori, Keiji Iwatsuki

Research output: Contribution to journalArticlepeer-review

Abstract

Psoriasis is a common chronic inflammatory skin disorder that is characterized by scaly, erythematous, sharply demarcated plaques. The treatment for psoriasis has dramatically changed over the last 10 years with the introduction of biologics. However, the risk of cancer induced by biologics for psoriasis has not been fully analyzed, since these agents have such a short history of use. Here we report the case of a 74-year-old woman with psoriasis vulgaris and psoriatic arthritis complicated by breast cancer after systemic treatments including etretinate, cyclosporine, methotrexate, adalimumab, and ustekinumab.

Original languageEnglish
Pages (from-to)185-187
Number of pages3
JournalActa medica Okayama
Volume72
Issue number2
Publication statusPublished - 2018

Keywords

  • Biologics
  • Malignancy
  • Psoriasis
  • Systemic therapy

ASJC Scopus subject areas

  • Biochemistry, Genetics and Molecular Biology(all)

Fingerprint

Dive into the research topics of 'A case of psoriasis complicated by breast cancer after systemic treatments including biologics'. Together they form a unique fingerprint.

Cite this